Target intelligence / Profile preview

Immunoglobulin kappa variable 6D-21 (IGKV6D-21)

Target
IGKV6D-21
Molecular classification
Other (Immunoglobulin variable region, not a receptor, enzyme, or transporter)
01

Overview

Immunoglobulin kappa variable 6D-21 (IGKV6D-21) encodes the variable (V) region segment of the immunoglobulin kappa light chain, which participates in the formation of the antigen binding site of immunoglobulins (antibodies)[1][5]. This variable region is critical for the diversity and specificity of antibody-mediated antigen recognition; it is generated through V(D)J recombination as part of B cell development, enabling the immune system to recognize a wide array of pathogens[1]. IGKV6D-21 is a protein-coding gene, but it is catalogued as "non-functional" and participates as part of the immunoglobulin complex present in the plasma membrane and extracellular region[1][5]. It does not act as a therapeutic target (e.g., receptor/enzyme), nor is it directly targeted by drugs; its primary biological role is in antibody variability and immune defense rather than as an isolated actionable target[1][5].

Other names
IGKV6D-21IGKV6D21A10Immunoglobulin kappa variable 6D-21KVD21
02

Biological functions

Antigen recognitionImmune response
03

Disease associations

Other (no known direct disease association; general role in immunity)

Beyond the preview

Go deeper on Immunoglobulin kappa variable 6D-21 (IGKV6D-21).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin kappa variable 6D-21 (IGKV6D-21).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call